JNJ Cumulative FCF
The running total of free cash flow across the series, showing cumulative cash generated to date.
Cumulative FCF
Latest: $288.21B (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | $174.79B |
| 2020Q4 | $182.02B |
| 2021Q1 | $186.02B |
| 2021Q2 | $190.57B |
| 2021Q3 | $198.13B |
| 2021Q4 | $202.49B |
| 2022Q1 | $206.11B |
| 2022Q2 | $210.89B |
| 2022Q3 | $216.23B |
| 2022Q4 | $220.22B |
| 2023Q1 | $222.65B |
| 2023Q2 | $225.78B |
| 2023Q3 | $232.43B |
| 2023Q4 | $238.82B |
| 2024Q1 | $241.88B |
| 2024Q2 | $246.90B |
| 2024Q3 | $253.92B |
| 2024Q4 | $259.34B |
| 2025Q1 | $263.00B |
| 2025Q2 | $265.89B |
| 2025Q3 | $273.97B |
| 2025Q4 | $279.45B |
| 2026Q1 | $280.91B |
| 2026Q2 | $288.21B |
Other JNJ Charts
More quarter-by-quarter fundamentals for Johnson & Johnson
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Shares Outstanding
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Cumulative FCF
Cumulative FCF
Cumulative FCF
Latest Cumulative FCF: $288.21B (2026Q2); +8.4% YoY; +38.5% CAGR since 2011Q1 (15.25y).
Across the 62 quarters from 2011Q1 to 2026Q2, Cumulative FCF ranged from $2.00B in 2011Q1 to $288.21B in 2026Q2.
Chart and table show the latest 24 of 62 quarters.